Did the ancient Greeks and Romans experience Alzheimer's?
You might think age-related dementia has been with us all along, stretching back to the ancient world.
Jan 31, 2024
1
59
You might think age-related dementia has been with us all along, stretching back to the ancient world.
Jan 31, 2024
1
59
Approximately four of five primary care clinicians consider themselves on the front lines of brain health. In the U.S., clinicians are the first point of contact for patients worried about memory loss and are most likely ...
Jan 29, 2024
0
0
About 55 million people worldwide are living with dementia, according to the World Health Organization. The most common form is Alzheimer's disease, an incurable condition that causes brain function to deteriorate.
Jan 26, 2024
0
1
A screening tool often used in primary care clinics to detect cognitive impairment has shortcomings when applied to ethnically and linguistically diverse older adults, according to a study published in the Journal of the ...
Jan 10, 2024
0
0
Comparing PET scans of more than 90 adults with and without mild cognitive impairment (MCI), Johns Hopkins Medicine researchers say relatively lower levels of the so-called "happiness" chemical, serotonin, in parts of the ...
Dec 7, 2023
0
8
A recent study demonstrated the safety of cilostazol in patients with mild cognitive impairment (MCI), but did not demonstrate any efficacy in preventing disease progression. However, after administration of cilostazol, the ...
Dec 6, 2023
0
0
We know sedentary behavior is bad for our health, especially for those of us who sit at a desk all day or in front of the TV each night. It has even been linked to mild cognitive impairment. Previous research has suggested ...
Nov 29, 2023
0
17
Two stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed.
Nov 20, 2023
0
0
Scientists at The University of Texas at Dallas Center for Vital Longevity (CVL) have published new evidence that shows changes in brain network patterns that occur in early-stage Alzheimer's disease differ from those associated ...
Nov 16, 2023
0
32
The use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to a study published in the Nov. 16 issue ...
Nov 16, 2023
0
0